Sonoma Pharmaceuticals, Inc.
Develops and sells stabilized HOCl products for wound, skin, eye, nasal, and animal healthcare.
SNOA | US
Overview
Corporate Details
- ISIN(s):
- US83558L2043
- LEI:
- Country:
- United States of America
- Address:
- 5445 CONESTOGA COURT, SUITE 150, 80301 BOULDER
- Website:
- https://sonomapharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Sonoma Pharmaceuticals, Inc. is a global healthcare company specializing in the development and commercialization of stabilized hypochlorous acid (HOCl) products based on its proprietary Microcyn® Technology. The company's portfolio addresses a wide range of applications, including advanced wound care, dermatology, eye care, nasal care, and animal health. Its products are utilized by healthcare professionals to treat various conditions such as chronic wounds and skin ailments. Sonoma Pharmaceuticals is recognized as a pioneer in its field, having introduced the first stable, patented HOCl-based formulation for wound management.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Sonoma Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sonoma Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sonoma Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
